Cellcom Israel, Ltd.
CEL
CEL was delisted on the 8th of February, 2021.
38 hedge funds and large institutions have $51.7M invested in Cellcom Israel, Ltd. in 2018 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 12 reducing their positions, and 5 closing their positions.
0% more funds holding
Funds holding: 38 → 38 (0)
0% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 5
23% less capital invested
Capital invested by funds: $67M → $51.7M (-$15.2M)
67% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 12
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $30K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$735K |
| 2 |
Marshall Wace
London,
United Kingdom
|
+$339K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$138K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$121K |
| 5 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$84.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DG
Delek Group
Herzliya,
Israel
|
-$6.42M |
| 2 |
Bank of New York Mellon
New York
|
-$1.68M |
| 3 |
EDRH
Edmond de Rothschild Holding
Chambesy,
Switzerland
|
-$198K |
| 4 |
AS
Altshuler Shaham
Tel Aviv,
Israel
|
-$122K |
| 5 |
MIH
Meitav Investment House
Bene-Beraq,
Israel
|
-$73.5K |
CEL Hedge Fund Activity: Q2 2018 in Review
38 of the 4,369 institutional investors tracked by Wall St. Rank reported a position in Cellcom Israel, Ltd. (CEL) for Q2 2018, worth a combined $51.7M — down 23% from $67M a quarter earlier.
Fund positioning in CEL was balanced in Q2 2018: 5 funds opened new positions, 5 closed out, 4 added to existing stakes and 12 trimmed.
The largest buyer was Arrowstreet Capital, opening a new position worth an estimated $735K. The largest seller was Delek Group, cutting an estimated $6.42M.
- 38 institutional investors held Cellcom Israel, Ltd. (CEL) as of Q2 2018, unchanged from Q1 2018.
- Funds reported $51.7M of Cellcom Israel, Ltd. stock for Q2 2018, down 23% quarter-over-quarter.
- 5 funds opened new Cellcom Israel, Ltd. positions in Q2 2018 and 5 closed out, a net change of 0 holders.
- The largest Cellcom Israel, Ltd. buyer in Q2 2018 was Arrowstreet Capital, an estimated $735K added.
- The largest Cellcom Israel, Ltd. seller in Q2 2018 was Delek Group, an estimated $6.42M sold.
Based on aggregated 13F filings for Q2 2018.